Free Trial

Straumann (OTCMKTS:SAUHF) Trading Up 12.9% - What's Next?

Straumann logo with Medical background
Image from MarketBeat Media, LLC.

Key Points

  • Shares jumped 12.9% to $107.95 on Thursday (from $95.58), but only about ~3 shares changed hands—well below the average daily volume of ~3,165—so the move may lack broad market participation.
  • The stock is still trading below its key technical levels, with the 50-day and 200-day moving averages around $115.87 and $116.21, respectively, implying ongoing short- and long-term resistance.
  • Straumann is a Swiss-based leader in restorative and regenerative dentistry, known for dental implants, prosthetics, biomaterials, digital dentistry technologies and practice/lab services, positioning itself as an end-to-end provider.
  • MarketBeat previews top five stocks to own in May.

Straumann Holding AG (OTCMKTS:SAUHF - Get Free Report) shares rose 12.9% during trading on Thursday . The stock traded as high as $107.95 and last traded at $107.95. Approximately 3 shares were traded during trading, a decline of 100% from the average daily volume of 3,165 shares. The stock had previously closed at $95.58.

Straumann Stock Up 4.0%

The company has a fifty day moving average of $115.87 and a 200-day moving average of $116.21.

Straumann Company Profile

(Get Free Report)

Straumann Group OTCMKTS: SAUHF is a Swiss-based developer and manufacturer of products and solutions for restorative and regenerative dentistry. The company is best known for its dental implant systems and related prosthetic components, and it has expanded its portfolio to include biomaterials, digital dentistry technologies, and practice- and laboratory-oriented services. Straumann positions itself as a provider of end-to-end solutions for clinicians, dental laboratories and dental practices aiming to restore oral function and aesthetics.

The Straumann product range covers titanium and ceramic implants, abutments, fixed and removable prosthetic solutions, bone grafting and regenerative materials, surgical instruments and guided-surgery systems.

See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Straumann Right Now?

Before you consider Straumann, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Straumann wasn't on the list.

While Straumann currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Click the link to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines